Haemonetics (HAE) Cash from Operations (2009 - 2026)

Haemonetics' Cash from Operations history runs 18 years deep, the most recent figure standing at 70941000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 39.14% year-over-year to 70941000.0 in Q1 2026; TTM through Mar 2026 was 293221000.0, a 61.35% increase from a year earlier, with the FY2026 full-year figure at 293221000.0, up 61.35% from the prior year.
• Cash from Operations declined to 70941000.0 in Q1 2026 per HAE's latest filing, from 93564000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 116557000.0 in Q1 2025 and bottomed at 27421000.0 in Q2 2024.
• The 5-year median for Cash from Operations is 64248000.0 (2022), against an average of 58902111.11.
• Biggest YoY gain for Cash from Operations was 8204.81% in 2024; the steepest drop was 243.67% in 2024.
• Year by year, Cash from Operations stood at 64415000.0 in 2022, then sank by 100.84% to 540000.0 in 2023, then soared by 8204.81% to 43766000.0 in 2024, then soared by 113.78% to 93564000.0 in 2025, then retreated by 24.18% to 70941000.0 in 2026.
• Per Business Quant, the three latest HAE Cash from Operations figures stand at 70941000.0 (Q1 2026), 93564000.0 (Q4 2025), and 111321000.0 (Q3 2025).